While A1C and fasting plasma glucose tests serve as key tools in detecting prediabetes and diabetes, recent research emphasises the importance of using both in tandem to improve diagnosis accuracy and patient outcomes, considering their different measures and limitations.
A1C and fasting plasma glucose are two of the main tools clinicians use to spot prediabetes and diabetes, but they do not answer exactly the same question. The CDC says A1C reflects average blood sugar over roughly the previous two to three months, while fasting plasma glucose shows the level at a single moment after an overnight fast. That difference matters because one test can be abnormal while the other is still normal, especially early in disease or when another condition is affecting red blood cells.
The practical thresholds are well established. The CDC and NIDDK say an A1C below 5.7% is normal, 5.7% to 6.4% points to prediabetes, and 6.5% or higher supports a diagnosis of diabetes. For fasting plasma glucose, a result below 100 mg/dL is normal, 100 to 125 mg/dL is in the prediabetes range, and 126 mg/dL or higher suggests diabetes. The NIDDK also notes that a two-hour oral glucose tolerance test can identify prediabetes and diabetes when fasting results do not tell the full story.
One reason the tests may disagree is that they measure different parts of glucose regulation. Harvard Health explains that A1C gives a longer view, while fasting glucose captures a single reading after at least eight hours without food. That means someone can have a normal fasting result but still show an elevated A1C, or the reverse. The difference can be especially important in early dysglycaemia, when blood sugar rises first after meals rather than overnight.
A1C is also less reliable in some medical situations. The CDC and NIDDK both note that red-cell disorders, recent blood loss or transfusion, kidney disease, liver disease and pregnancy can distort the result. Iron deficiency can push A1C higher in some people, and haemoglobin variants may interfere with certain lab methods. That is why clinicians often turn to fasting glucose or an oral glucose tolerance test when A1C does not fit the wider clinical picture.
Prediabetes should be treated as a warning sign, not a verdict. NIDDK guidance frames it as a risk state that raises the chance of developing type 2 diabetes, but progression is not inevitable. Lifestyle changes such as weight loss where appropriate, more physical activity and improved diet can delay or prevent diabetes in many high-risk adults. The key point is that risk rises towards the upper end of the prediabetes range, so follow-up and prevention matter.
Once diabetes is diagnosed, A1C becomes a monitoring tool rather than a diagnostic one. The ADA says many adults aim for an A1C near 7%, but targets are individualised based on age, hypoglycaemia risk, complications and overall health. A lower number is not always better if it comes with frequent lows, and continuous glucose monitoring can reveal swings that A1C alone hides.
The safest way to read these tests is to use them together and in context. A borderline result should usually be confirmed, particularly if the person has no clear symptoms. Diabetes care also changes when pregnancy, anaemia, haemoglobin disorders or severe illness are involved. Used properly, A1C and fasting plasma glucose complement each other: one offers a longer view, the other a standardised snapshot.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
